ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Lubrizol exiting drug compounds

April 10, 2006 | APPEARED IN VOLUME 84, ISSUE 15

Lubrizol has agreed to sell its business in active pharmaceutical ingredients and intermediates to Auctus Management, a German private equity firm. The business, which is expected to have sales this year of about $30 million, includes facilities in Raubling, Germany, and Chennai, India. Lubrizol says this is the fifth and last divestiture since its announcement last year that it would sell off businesses with combined annual revenues of $500 million.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment